Header cover image

Pharmaceuticals & Biotech Consumer Discretionary

Results

1272

0 new

All the companies in the consumer discretionary sector including household durables, leisure products and luxury goods.

1,272 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

QURE

uniQure
US$5.080.6%-17.8%US$247.4mUS$19.69PS8.9xE28.0%n/a

TRVI

Trevi Therapeutics
US$3.330.9%64.0%US$241.7mUS$9.11PB3.7xE7.5%n/a

BDTX

Black Diamond Therapeutics
US$4.23-6.0%52.2%US$239.0mUS$14.83PB2.2xE-7.7%n/a

FULC

Fulcrum Therapeutics
US$3.7717.8%-7.8%US$235.3mUS$5.29PS2.9xE-22.6%n/a

CADL

Candel Therapeutics
US$7.213.9%593.3%US$231.3mn/aPE-4.6xn/an/a

SCPH

scPharmaceuticals
US$4.61-4.2%-29.7%US$230.6mUS$19.80PS9.6xE66.3%n/a

CDXS

Codexis
US$3.2310.6%63.1%US$229.1mUS$7.17PS3.8xE46.6%n/a

OMER

Omeros
US$3.924.0%41.5%US$227.2mn/aPE-1.1xE38.2%n/a

MRSN

Mersana Therapeutics
US$1.85-4.9%46.8%US$226.9mUS$6.50PS7.6xE12.4%n/a

KYTX

Kyverna Therapeutics
US$5.23-10.5%n/aUS$225.7mUS$34.40PB0.6xE-26.7%n/a

INBX

Inhibrx Biosciences
US$15.52-1.0%n/aUS$224.7mn/aPE0.1xn/an/a

CAVG

ACC Aviation Holdings
US$0.890%196.0%US$224.6mn/an/an/an/a

MACK

Merrimack Pharmaceuticals
US$15.130.07%21.7%US$223.7mn/aPB1xn/an/a

ACRV

Acrivon Therapeutics
US$7.16-1.0%-20.4%US$221.8mUS$21.67PB1xE-2.9%n/a

XBIT

XBiotech
US$7.216.2%87.3%US$219.6mn/aPB1.1xn/an/a

GOSS

Gossamer Bio
US$0.96-4.0%24.9%US$217.2mUS$6.72PS2.3xE23.2%n/a

NKTR

Nektar Therapeutics
US$1.17-2.5%105.3%US$215.4mUS$1.30PS2.3xE4.7%n/a

PYXS

Pyxis Oncology
US$3.620.6%76.6%US$215.1mUS$9.20PS13.3xE-23.9%n/a

ENTA

Enanta Pharmaceuticals
US$10.05-8.6%-4.2%US$212.9mUS$19.63PS3xE-2.7%n/a

SPPI

Spectrum Pharmaceuticals
US$1.035.3%17.0%US$209.9mUS$1.26PS8.2xE67.3%n/a

AMLX

Amylyx Pharmaceuticals
US$3.085.8%-83.0%US$209.7mUS$4.25PB0.8xE27.7%n/a

CABA

Cabaletta Bio
US$4.26-2.5%-71.5%US$208.1mUS$24.33PB1xE1.2%n/a

BTMD

biote
US$5.67-5.7%13.4%US$205.3mUS$9.59PE25.6xE73.3%n/a

TELO

Telomir Pharmaceuticals
US$6.82-6.3%n/aUS$201.9mn/aPB128.8xn/an/a
Page 17 of 53
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.